Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol ED95 for Sedation in Elderly Knee Arthroplasty
NCT06293144Phase 1Recruiting
- Sponsor
- The Second Hospital of Shanxi Medical University
- Start
- Nov 2023
- Primary completion
- May 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ciprofol, sponsored by The Second Hospital of Shanxi Medical University. Primary endpoints: Modified Alertness Sedation Score at 24 hours and Bispectral Index at 24 hours. Started Nov 2023; status: recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on NCT06293144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06293144.